Sandoz has celebrated across-the-board growth in 2023, as the now standalone company delivered its first annual results since its October spinoff from former parent Novartis.
Sandoz Celebrates Growth As It Delivers First Standalone Annuals
North America Bump Of 20% In Q4 Enables Region To Register Growth In 2023
An upbeat Sandoz pointed to growth across all its regions and businesses in 2023, as the firm delivered its first annual results as a standalone company.
